Home/Filings/4/0001140361-11-004495
4//SEC Filing

Kramarz Michael Anthony 4

Accession 0001140361-11-004495

CIK 0000799694other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 7:17 AM ET

Size

19.7 KB

Accession

0001140361-11-004495

Insider Transaction Report

Form 4
Period: 2011-01-26
Transactions
  • Disposition to Issuer

    Stock Options (Common Stock)

    2011-01-26$1.33/sh45,000$59,850210,000 total
    Exercise: $1.33From: 2004-09-16Exp: 2012-09-16Common Stock (45,000 underlying)
  • Disposition to Issuer

    Stock Options (Common Stock)

    2011-01-26$0.50/sh30,000$15,000170,000 total
    Exercise: $0.50From: 2003-10-06Exp: 2013-10-06Common Stock (30,000 underlying)
  • Disposition to Issuer

    Stock Options (Common Stock)

    2011-01-26$0.17/sh20,000$3,300100,000 total
    Exercise: $0.17From: 2005-03-24Exp: 2015-03-24Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Options (Common Stock)

    2011-01-26$0.40/sh100,000$40,0000 total
    Exercise: $0.40From: 2007-03-22Exp: 2013-03-22Common Stok (100,000 underlying)
  • Disposition to Issuer

    Stock Options (Common Stock)

    2011-01-26$0.53/sh10,000$5,300200,000 total
    Exercise: $0.53From: 2002-12-12Exp: 2012-12-12Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Options (Common Stock)

    2011-01-26$0.23/sh50,000$11,500120,000 total
    Exercise: $0.23From: 2004-07-15Exp: 2014-07-15Common Stock (50,000 underlying)
  • Award

    Stock Options (Common Stock)

    2011-01-26$0.03/sh+51,000$1,53051,000 total
    Exercise: $0.03From: 2011-01-07Exp: 2018-01-07Common Stock (51,000 underlying)
Footnotes (2)
  • [F1]On January 7, 2001, the Board of Directors of the Issuer determined that it would be in the best interest of the Company and its shareholders to reduce the number of authorized but unissued shares of common stock to outstanding stock purchase rights. If successfully accomplished, such reduction would serve to increase the number of shares available for the sale to finance the continuing operations of the Company. Accordingly, the board of Directors specifically authorized the exchange of presently outstanding rights to purchase 1,475,000 shares at prices between $0.165 and $1.33 for the rights to purchase up to 295,000 shares at a price of $0.03 per share. The transaction being reported on hereby reflects the acceptance by the filer of such exchange. The exchange was made on January 26, 2011.
  • [F2]Mr. Kramarz holds a direct interest in 51,000 stock options to purchase common stock.

Documents

1 file

Issuer

Oncologix Tech Inc.

CIK 0000799694

Entity typeother

Related Parties

1
  • filerCIK 0001298229

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 7:17 AM ET
Size
19.7 KB